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Abstract
Inducible gene expression plays a central role in neuronal plasticity, learning, and memory, and dysfunction of the
underlying molecular events can lead to severe neuronal disorders. In addition to coding transcripts (mRNAs), non-coding
microRNAs (miRNAs) appear to play a role in these processes. For instance, the CREB-regulated miRNA miR132 has been
shown to affect neuronal structure in an activity-dependent manner, yet the details of its physiological effects and the
behavioral consequences in vivo remain unclear. To examine these questions, we employed a transgenic mouse strain that
expresses miR132 in forebrain neurons. Morphometric analysis of hippocampal neurons revealed that transgenic miR132
triggers a marked increase in dendritic spine density. Additionally, miR132 transgenic mice exhibited a decrease in the
expression of MeCP2, a protein implicated in Rett Syndrome and other disorders of mental retardation. Consistent with
these findings, miR132 transgenic mice displayed significant deficits in novel object recognition. Together, these data
support a role for miR132 as a regulator of neuronal structure and function, and raise the possibility that dysregulation of
miR132 could contribute to an array of cognitive disorders.
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Introduction
microRNAs (miRNAs) are small, evolutionarily conserved,
molecules that act as potent silencers of gene expression via
translational repression and/or mRNA destabilization [1]. Since
their characterization in C. elegans [2,3], there has been an
explosion of studies revealing fundamental and critical roles for
miRNAs in virtually all aspects of cell biology.
Within the nervous system, a good number of miRNAs exhibit
developmentally-dependent and cell-type-specific, expression pat-
terns [4–7]. Further, recent work has shown that miRNAs can be
expressed in an activity-dependent manner [8,9]. Within this
context, particular attention has been paid to the miRNA132
(miR132). miR132 is processed from the intron of a small non-
coding RNA gene and is robustly responsive to an array of
physiological and pathophysiological stimuli [10–16]. With respect
toneuronal function,miR132has been showntoinfluencedendritic
growth and spinogenesis in cultured hippocampal neurons and in
brain slices [10,12,17]. Some of these effects appear to be mediated
by the down regulation of the miR132 target p250GAP, which, in
turn, allows for Rac1-PAK-mediated spinogenesis [12,13]. Inter-
estingly, expression of methyl CpG–binding protein 2 (MeCP2) is
also tightly regulated by miR132 [18], and altered expression of
MeCP2 has been shown to be an underlying element in the
development of Rett syndrome, a neuro-developmental disorder in
which dendritic development and synaptogenesis are affected [19–
21]. Thus, miR132 appears to be well-positioned to couple synaptic
activity to neuronal structural/functional plasticity.
To begin to address the potential role of miR132 in vivo,w e
developed a transgenic mouse strain that over-expresses miR132
in forebrain neurons. Morphometric analysis revealed a marked
effect of transgenic miR132 on hippocampal neuronal morphol-
ogy. Concordant with this, there was a decrease in MeCP2
expression in hippocampus. Furthermore, we show that these mice
have impaired hippocampal-dependent object recognition mem-
ory. Collectively, these data reveal miR132 as a potent regulator of
neuronal structure and CNS function.
Materials and Methods
Ethics Statement
All animal breeding and experimental procedures were
approved by the Ohio State University Animal Care and Use
Committee (protocol number: 2008A0227).
Generation of miR132 transgenic mice
The tetracycline regulated bi-directional pBI-G vector (Clon-
tech, Mountain View CA) was modified by removing the lacZ
coding region, and replacing it with enhanced cyan fluorescent
protein (CFP: subcloned from the pCX-ECFP vector). To shorten
the half-live of CFP, and thus allow for a more dynamic read-out
of transgene expression, the mouse ornithine decarboxylase PEST
sequence was subcloned, in frame, to the 59 end of CFP. The
premiR132 sequence from the pCAG-miR132 vector [10] was
subcloned into the multiple cloning site of the pBI-CFP vector to
generate the final TET-response element-controlled miR132-CFP
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procedures: pronuclear injection of FVB/N oocytes with the
linearized construct was performed Dr. Xin-An Pu, at the Ohio
State University Transgenic Facility. Five lines were generated and
analyzed for transgene expression by crossing to the CaMKII tTA
driver line [22]. The line with the broadest neuroanatomical
expression pattern was retained and backcrossed to the C57BL/6J
mouse strain a minimum of 6 times. Of note, at no point were the
animals administered with doxycycline. Thus the miR132
transgene was constitutively expressed. Thy-1 GFP mice [23]
were generously provided by Gouping Feng (Duke University).
RT-PCR miRNA quantitation
Total hippocampal and cortical RNA was isolated, and reverse-
transcribed using the miScript Reverse Transcription Kit (Qiagen,
Valencia, CA USA). miRNAs were polyadenylated with Poly(-
A)polymerase before reverse transcribing with universally-tagged
59 oligo-dT primer (Qiagen). cDNA was then amplified and
miR132 was quantified by real-time PCR analysis using the
miScript Primer System (Qiagen). Data were normalized to
RNU6B_2 cDNA levels.
Tissue Processing and Immunolabeling
Brain tissue was removed after cervical dislocation and postfixed
in 4% paraformaldehyde for 4 h at 4uC and cryoprotected with
30% sucrose in PBS. Brains sections (500 mm thick) were prepared
using a vibratome and hippocampus-containing sections were then
thin-cut (40 mmo r8 0mm think) on a freezing microtome.
For immunohistochemical labeling, sections were washed in
PBS and blocked with 10% normal goat serum in PBS, and then
treated with 0.3% hydrogen peroxide. Sections were then
incubated overnight (4uC) with rabbit polyclonal anti-MeCP2
antibody (1:3000 dilution; Cell Signaling, Davners, MA). Next, the
tissue was incubated for 2 h at room temperature in biotinylated
anti-rabbit IgG (1:300; Vector Laboratories) and then placed in an
avidin/biotin HRP complex (Vector Laboratories, Burlingame,
CA) for 1 h, following the manufacturer’s instructions. The signal
was visualized using nickel-intensified DAB substrate (Vector
Laboratories), and sections were mounted on gelatin-coated slides
with Permount media (Fisher Scientific, Petaluma, CA). Sections
were washed in PBS (three times, 10 min per wash) between each
labeling step.
Sections used for immunofluorescent labeling were washed and
permeabilized in PBS with 1% Triton X-100 PBST for a total of
30 min. Sections were then blocked for 1 h in10% normal goat
serum in PBS and incubated (overnight, 4uC) in mouse anti-NeuN
antibody (1:3000; Millipore, Billerica, MA) and/or rabbit
polyclonal anti-GFP antibody (acquired from Dr. Luc G.
Berthiaume, University of Alberta, Canada). The GFP antibody
was used at 1:2,500 to detect the TRE-regulated CFP transgene
and 1:20,000 to detect the thy1-regulated GFP transgene.
Next, sections were incubated (3 h at room temperature) in
Alexa Fluor-594-conjugated goat anti-rabbit IgG antibody
(1:1000; Invitrogen, Carlsbad, CA) and/or Alexa Fluor-488-
conjugated goat anti-mouse IgG antibody (1:1000; Invitrogen).
Tissues were washed in PBST (three times, 10 min per wash)
between each labeling step. Sections were mounted on slides with
Flouro-Gel (Electron Microscopy Sciences, Hatfield, PA).
Analysis
Morphological changes in CA1 basal dendrites (ten per animal)
were examined over two 40 mm-thick coronal sections per animal.
Confocal images of Thy-1 GFP immunofluorescence were
captured 90–120 mm from the cell soma and spines were
examined over 20 mm dendritic segments. Processes that extended
.0.5 microns from the dendrite were counted. Of note, processes
that had a mushroom-shaped morphology and from those with a
filopodia-like morphology (i.e., long, thin, protrusions) were
counted and are referred to here as ‘spines’. Images were acquired
at 636with 4.36optical zoom, using a Zeiss 510 Meta confocal
microscope and LSM Software Zen.
MeCP2 labeling images were acquired at 106 using a 16 bit
digital camera (Micromax YHS 1300; Princeton Instruments)
mounted on an inverted Leica microscope (DM IRB). Images of
the granule cell layer (GCL) and CA1 of MeCP2 labeled sections
were traced digitally and intensity levels were analyzed with
MetaMorph software (Molecular Devices). Intensity levels were
normalized by background subtraction and presented relative to
nontransgenic CA1 staining.
Western Blotting
Isolated hippocampal tissue was lysed in 100 ml radioimmuno-
precipitation assay buffer (50 mM Tris-HCl, 150 mM NaCl,
1 mM EDTA, 1% Triton X-100, 0.1% sodium dodecyl sulfate,
1% sodium deoxycholate, 1 mM sodium vanadate, 1 mM NaF,
and 16protease inhibitor cocktail (Roche). Protein extracts (5 mg/
lane) were electrophoresed into a 10%SDS-PAGE gel and then
transblotted onto polyvinylidene difluoride membranes (Immobi-
lon-P; Millipore). Membranes were blocked in 5% milk in PBST
and then incubated (overnight, 4uC) in PBST (with 5% BSA) with
the MeCP2 antibody (1:6000; Cell Signaling). Next, membranes
were incubated in PBST (with 5% milk) with an anti-goat IgG
horseradish peroxidase-conjugated antibody (1:2000; Jackson
Laboratories). As a protein loading control, membranes were
probed for ERK1 expression using a goat polyclonal anti-ERK1
antibody (1:1000; Santa Cruz Biotechnology) followed by anti-
goat IgG antibody conjugated to horseradish peroxidase (1:2000;
PerkinElmer Life Sciences). The signal was visualized using the
Western Lighting Chemiluminescence light-emitting system (Per-
kinElmer Life Sciences) and HyBlot CL autoradiography film
(Denville Scientific). Between each antibody treatment, mem-
branes were washed a minimum of four times (10 min per wash) in
PBST. Densitometric band analysis was performed using Photot-
shop (Adobe Systems). For each lane, MeCP2 and ERK1 band
intensity was background subtracted, and the MeCP2 signal was
divided by the ERK1 signal; mean data for each group were
derived from three animals (biological replicates) per condition.
Behavioral Analysis
Novel object recognition was adapted from procedure described
by Bevins and Besheer [24]. Each animal was allowed a 10 min
training session with exposure to two identical, non-toxic objects
(glass or hard plastic items) placed in the back left and right
corners of the arena. After the training session, the animal was
returned to its home cage for a 30-min retention interval. For
testing, each animal was lowered into to the testing arena in which
one familiar object was replaced with a novel object. The animal
was lowered into the arena, equidistant and facing away from each
object. Each session was video record and the animal was given
5 min to explore. The time spent exploring each object was scored
for each mouse from the video. Exploration was defined as the
animal’s nose being within 2 cm of and pointed toward the object.
Time during which the animal propped itself up on the object in
order to explore higher levels of the arena was not considered
exploration time for that object. The discrimination ratio was
calculated as the time spent with the novel object divided by the
total time spent exploring either object. Objects were randomized
and counterbalanced across animals and groups. Objects and
miR132 Actions In Vivo
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to prevent olfactory cues.
Of note, the visual ability of each mouse was assessed by
suspending the animal by the tail and slowly lowering it toward a
sold dark surface (a table) for three successive trials. Visual acuity was
demonstrated by the animal’s reaching for the surface before vibrissae
made contact with it. All mice demonstrated full visual capability.
Statistics
All values in the paper are given as means 6SEM and
comparisons between groups were made by Student’s t-test with
significance set as p,0.05 unless otherwise noted. Significance for
novel object recognition was assessed using one-way ANOVA
analysis followed by Fisher’s least significant difference (LSD) test.
A value of p,0.05 was accepted as statistically significant.
Results
Bitransgenic expression of tTA::miR132 in vivo
To explore the functional role of miR132 in vivo, our lab
generated a tetracycline response transgenic mouse strain, which
bidirectionally drives the expression of miR132 and cyan
fluorescent protein (CFP). To target transgene expression to the
forebrain neurons, these mice were crossed with mice expressing
tTA via the CaMKII promoter [22] (Fig. 1A, B). Quantitative
real-time RT-PCR revealed that the transgene lead to an ,7-fold
Figure 1. miR132/CFP transgene expression. (A) PCR-based genotyping results for the tTA and miR132; of note, only mouse #4 contains both
the tTA and miR132 transgenes. PCR reactions were run in a 1% agarose gel and visualized using ethidium bromide. (B) To confirm miR132
overexpression in tTA::miR132 mice, total hippocampal and cortical RNA was isolated, reverse-transcribed, and the miR132 cDNA was profiled via real-
time PCR. Normalized mature miR132 levels are shown as mean 6SEM, compared to nontransgenic controls (NT: n=3 animals per condition). Data
were normalized to RNU6B_2 cDNA levels. Representative transgene expression in vivo. (C) Coronal brains sections were immunolabeled for the CFP
transgene marker. Note the robust transgene expression within the cortex (CTX), hippocampus (Hip) and striatum (Str). (D) Double
immunofluorescent labeling for CFP and NeuN reveals that hippocampal excitatory neurons of the GCL and the CA1 and CA3 sublayers express
the transgene. Arrows denote the location of nontransgenic neurons adjacent to the excitatory cell layers. Scale bars: 50 mm.
doi:10.1371/journal.pone.0015497.g001
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genic littermates (Fig. 1B). Immunolabeling for CFP detected the
expected expression pattern within forebrain regions, including the
hippocampus and cortex (Fig. 1C). Further, double immunoflu-
orescence labeling for CFP and the neuronal nuclear antigen
(NeuN) revealed that cells with the pyramidal morphology,
indicative of glutamatergic neurons, robustly expressed the
transgene (Fig. 1D).
Figure 2. Hippocampal expression of Thy1-GFP. (A) Representative GFP fluorescent immunolabeling of the dorsal hippocampus. A limited
subset of CA1 pyramidal neurons and granule cells express the GFP transgene. GCL, granule cell layer; CA1, hippocampal subfield; H, hilus. Framed
CA1 pyramidal cell is shown at higher magnification (B), as well as a confocal image of a CA1 dendrite (C). (D) Immunolabeling for TRE-regulated CFP
expression in a tTA::miR132 transgenic mouse. At the antibody concentration used to reveal Thy-1 driven GFP expression (presented in A), minimal
expression of CFP was detected. (E) As a further control, wild type (WT) tissue was immunolabeled using the GFP antibody: minimal non-specific
labeling was detected. Of note, all images presented here (except for the confocal image in C) used identical data collection and analysis settings.
Scale bars: 200 mm in A, 100 mmi nB ,1 0mm in C, 200 mmi nD .
doi:10.1371/journal.pone.0015497.g002
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neurons
Given prior work showing that miR132 affects the morphology
of cultured neurons, we initially examined neuronal ultrastructure
in tTA::miR132 mice. To this end, the tTA::miR132 mice were
crossed with a transgenic line expressing green fluorescent protein
(GFP) under the control of the thy1 promoter. Thy-1 is expressed
by projection neurons throughout many areas of the nervous
system [25] and its promoter is used to transgenically drive robust
GFP expression in a subpopulation of hippocampal neurons [26].
Importantly, Thy1-driven morphological marker does not affect
the electrophysiological or the morphological properties (i.e.,
dendrite length and number, spine number and density, soma size)
of hippocampal neurons [26]. Of note, for all morphometric
studies, we employed a fluorescent immunolabeling approach,
which increased (relative to native GFP fluorescence) our ability to
detect the transgene. Notably, the expression level of the tet-
responsive CFP transgene (which is also antigenic to the GFP
antibody) was markedly lower than the Thy-1 driven GFP, and
thus, we were able to selectively visualize the Thy-1 GFP transgene
by using a relatively low concentration (1:20,000) of the primary
antibody. In support of this approach, immunofluorescence
labeling of tTA::miR132 tissue with this antibody concentration
did not allow for clear visualization of the CFP reporter (Fig. 2D).
As a relative comparison, wild-type tissue was also labeled using
the GFP antibody (Fig. 2E). Further, quantitative analysis of the
immunofluorescence signal intensity did not detect a significant
additive effect of Thy-1 GFP and miR132-CFP reporters, relative
to Thy-1 GFP labeling alone (data not shown).
Changes in dendritic morphology of tTA::miR132 mice
The spine density of CA1 neurons expressing the Thy1-GFP
hippocampal neurons was measured from coronal sections over
20 mm lengths of basal dendrites from Thy-1::tTA::miR132 triple
transgenic mice and from Thy-1::tTA: control littermates (Fig. 3A,
B). Consistent with previous in vitro data on miR132, mice that
express transgenic miR132 showed a significant increase in spine
density in CA1 neuronal dendrites over Thy-1::tTA: control
littermates. These data indicate that miR132 modulates neuronal
structural features associated with synaptic communication.
Decreases in MeCP2 levels in the tTA::miR132
hippocampus
Given recent work using in vitro model systems showing that
MeCP2 is a target of miR132 [18], we investigated whether
transgenic miR132 affected MeCP2 levels in the hippocampus.
Immunohistochemical labeling revealed significant decreases in
MeCP2 expression in both the CA1 cell layer and GCL of
tTA::miR132 mice, relative to control littermates that only express
tTA (Fig. 4A-C). Western analysis of hippocampal lysates, showed
a parallel attenuation of MeCP2 expression in tTA::miR132
versus tTA transgenic animals (Fig. 4D and E). These data support
the aforementioned studies and thus, raise the possibility that
transgenic miR132 could affect cognitive function.
Overexpression of miR132 impairs novel object
recognition memory
To elucidate the behavioral ramifications of transgenic miR132,
we examined the recall memory of tTA::miR132 mice using a
novel object recognition task. After two days of fifteen-min
habituation trials in the testing field, mice were allowed to explore
two identical objects for ten min and were then returned to their
home cages. After a delay period of 30 min, one familiar object
was replaced with a similar but novel object and the mice were
allowed another five min of exploration time during which their
interaction time with each object was measured. As expected in
animals with a fully intact recall memory, monotransganic
littermate control mice (i.e., tTA mice lacking the responder gene,
and miR132 transgenic mice lacking the driver gene) spent more
time with the novel object than the familiar one. In contrast
however, tTA::miR132 bitransgenic mice showed no discrimina-
tion between the novel and familiar objects (Fig. 5). These data
reveal a profound cognitive deficit resulting from dysregulation/
overexpression of miR132.
Discussion
Here, we explored the role of miR132 in vivo using a
bitransgenic tTA::miR132 mouse model, in which miR132 was
over expressed in excitatory neurons throughout the forebrain.
Using a thy1-GFP morphological marker, we demonstrated that in
CA1 pyramidal neurons, transgenic miR132 induces an increase
in dendrite spine density. This finding is consistent with recent
work using cell culture and brain slice-based methodologies, which
showed that miR132 increased spinogenesis [13]. Further, the
work of Impey et al. [13] showed that miR132 regulates synapse
formation and function, thus raising the possibility that over-
expression of miR132 affects synaptic communication in vivo.
Future studies will examine this question in detail.
Figure 3. Transgenic miR132 affects neuronal morphology. (A)
Representative confocal images of CA1 pyramidal neuron basal
dendrites from tTA::miR132 transgenic and tTA monotransgenic tissue.
Note the increased spine density in the tTA::miR132 dendrite compared
the tTA transgenic mouse. (B) Graphical representation of the mean 6
SEM spine density. **P,0.01, two-tailed t-test, n=6 animals for each
group. Please see the Methods section for a description of the
quantification methods. Scale bar: 10 mm.
doi:10.1371/journal.pone.0015497.g003
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level, we examined the expression of MeCP2. This examination
was based, in part, on recent work showing that the brain-enriched
‘long-form’ 39 UTR of MeCP2 contains a phylogenetically
conserved miR132 binding site, and that miR132 transfection of
cortical neurons leads to a marked attenuation of MeCP2
expression [18]. Our data are consistent with these findings:
transgenic miR132 led to a significant reduction in MeCP2
expression in the hippocampus.
Beyond simply validating the function of transgenic miR132,
the data presented here, showing a down-regulation of MeCP2,
has potentially significant ramifications for cognitive performance.
MeCP2 is a multifunction protein that has been implicated in both
the negative regulation of gene expression and RNA splicing [27].
As noted above, dysregulation of MeCP2 is associated with
neuronal developmental abnormalities in Rett Syndrome [19–21].
Interestingly, in both Rett syndrome and in MeCP2-deficient
mice, forebrain neurons exhibit a reduction in spine density [28].
This effect is somewhat inconsistent with the increase in spine
density observed in the miR132 mice. One potential explanation
for this discord is that miR132 targets a large number of mRNA
species, some of which, such as p250 GAP, have been shown to
increase neuronal complexity [29,12]. Thus, the morphological
phenotype observed here is the likely result of a complex interplay
of loss- and gain-of-function physiological effects. Nevertheless,
our data showing that miR132 markedly affects MeCP2
expression in vivo, provide a strong rationale for examining
whether dysregulation of miR132 could be contributing to Rett
Syndrome and other MeCP2-related disorders.
The effects of transgenic miR132 on both spine density and
MeCP2 expression raised the possibility that miR132 influences
cognitive performance. Indeed, we found that tTA::miR132 mice
performed poorly on a hippocampal-dependent novel object
recognition task, which is designed to test the integrity of
recognition memory [24,30]. This observation is of particular
interest, given that the expression of endogenous miR132 is under
the control of CREB [10], a transcription factor that plays a key
role in regulating activity-dependent neuronal plasticity [31].
Interestingly, for optimal cognitive performance CREB-dependent
transcription must be maintained within a limited range; hence,
excessive CREB-mediated gene expression has been shown to
interfere with hippocampal-dependent learning and memory [32].
This observation is consistent with our data on transgenic miR132
over-expression, and raises the interesting prospect that a more
Figure 4. Decreased MeCP2 expression in tTA::miR132 mice. A and B: Top panels) Representative immunohistochemical labeling for MeCP2
in the dorsal hippocampus of tTA monotransgenic (A) and tTA::miR132 bitransgenic (B) mice. Relative to tTA littermates, mice over-expressing
miR132 showed a decrease in MeCP2 expression within the excitatory cell layers of the hippocampus. Scale bar: 200 mm. Middle and bottom panels)
High magnification images of MeCP2 labeling within area CA1 and the GCL are presented. Scale bar: 100 mm. (C) Quantitative analysis of the mean 6
SEM MeCP2 expression in area CA1 and the GCL. Of note, MeCP2 expression was significantly reduced in tTA::miR132 mice (n=7) compared to
monotransgenic controls (n=8) (**P,0.01, *P,0.05). (D) Western analysis of biological replicates (two animals per condition) confirming the
reduction in MeCP2 expression in tTA::miR132 mice, along with quantitative densitometric analysis relative to endogenous ERK1 levels (E), presented
as mean 6 SEM (n=3) (*P,0.05).
doi:10.1371/journal.pone.0015497.g004
Figure 5. Decreased memory capability in mice over express-
ing miR132. Memory in tTA::miR132 bitransgenic mice was measured
by novel object recognition. In contrast to monotransgenic littermates
(tTA and miR132), which spent more time exploring novel objects than
familiar ones, tTA::miR132 mice showed no significant capacity for
object discrimination. Data are presented as mean discrimination ratio
6SEM, ANOVA F(2,15) =7.351, *p,.006, n=6 for each group.
doi:10.1371/journal.pone.0015497.g005
miR132 Actions In Vivo
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role for miR132 in learning and memory. Future studies in which
transgenic expression of miR132 is carefully titered with
doxycycline will test this possibility.
In conclusion, the findings reported here, coupled with prior
work, indicate that miR132 is part of an activity-dependent gene
expression program that underlies neuronal plasticity. Further
work examining miR132 functionality in both health and disease
in merited.
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